This invention discloses and claims diary heterocycles of formula (I)
##STR00001## and their pharmaceutically acceptable salts, pharmaceutical
compositions thereof, and methods of using said compounds of formula (I)
for the treatment or prevention of excessive weight or obesity, and for
treatment of Type II diabetes, arteriosclerosis, high blood pressure,
depression, anxiety, anxiety neuroses, and schizophrenia. Methods for
treatment of excessive weight or obesity and for treatment of Type II
diabetes with a mixture of a compound of formula I and antiobesity agents
or appetite-regulating active ingredients, or with a mixture of a
compound of formula I and antidiabetics or hypoglycemic active
ingredients are also disclosed and claimed.